KMDA MEXC RealStocks
Own real KMDA shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 08:30:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Kamada Ltd (KMDA) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $8.08, with a market capitalization of $471.09M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.60 to $9.35. This page covers its latest market performance, valuation, price trends and company information.
$471.09M | |
$8.32 | |
$8.32 | |
$8.02 | |
$8.16 | |
148.84K | |
121.80K | |
-- | |
$9.35 | |
$6.60 | |
-- | |
2026-09-30 |
Kamada Ltd (KMDA) last closed at $8.08 as of 2026-11-18 21:38:00, down 0.98% ($0.08) from the previous close of $8.16.
During the latest regular trading session, KMDA traded between $8.02 and $8.33, with a volume of 148.84K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Kamada Ltd (KMDA) moved from $8.10 to $8.08, representing a decline of 0.28% ($0.02).
The stock traded between $7.90 and $8.35 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 123.38 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 53.8%
KMDA is currently trading at $8.08, placing it 53.8% of the way from its 52-week low of $6.60 to its 52-week high of $9.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
| Employees | 462 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Kamada Ltd.
Dividend | |
|---|---|
| Ex-Dividend Date | Nov 19, 2026 |
| Payment Date | Dec 9, 2026 |
| Dividend Per Share | $0.14 |
Eligible investors can buy real shares of Kamada Ltd (KMDA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to KMDA, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between KMDA shares and USD.
KMDA Shares to USD
1.00 KMDA shares = 8.077 USD
Calculations are estimates based on the latest available price and are for reference only.